Regeneron On Pace for Largest Percent Decrease Since November 2021 -- Data Talk
03 June 2022 - 1:37AM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $628.00,
down $30.92 or 4.69%
--Would be lowest close since May 11, 2022, when it closed at
$613.05
--On pace for largest percent decrease since Nov. 5, 2021, when
it fell 5.57%
--Currently down four of the past five days
--Currently down three consecutive days; down 9.35% over this
period
--Worst three day stretch since the three days ending March 20,
2020, when it fell 10.83%
--Down 0.56% year-to-date
--Down 15% from its all-time closing high of $738.84 on April 8,
2022
--Up 24.19% from 52 weeks ago (June 3, 2021), when it closed at
$505.66
--Down 15% from its 52-week closing high of $738.84 on April 8,
2022
--Up 24.19% from its 52-week closing low of $505.66 on June 3,
2021
--Traded as low as $617.21; lowest intraday level since May 12,
2022, when it hit $606.77
--Down 6.33% at today's intraday low; largest intraday percent
decrease since Nov. 5, 2021, when it fell as much as 8.2%
--Fifth worst performer in the S&P 500 today
--Third worst performer in the Nasdaq 100 today
All data as of 11:04:38 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 02, 2022 11:22 ET (15:22 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024